On the mend: Public and private health insurance providers will challenge industry operators

The Brand-name Pharmaceutical industry in Canada has endured strong competitive pressures from generic drugs by innovating its product line and attracting higher demand from Canadians. In response to many brand-name drugs losing their patent protection, many industry operators streamlined their operations. As more Canadians using high-cost prescriptions, including oncology, biotechnology and specialty drugs, many provinces have implemented mandatory low prices for generic drugs, which has intensified competition for the industry. This has been in an effort to improve the affordability of essential drugs and reducing healthcare costs. Many pharmaceutical manufacturers are expected to focus their product portfolio on developing biologic drugs...read more.

Industry Statistics & Market Size
Revenue
$8bn
Annual Growth 14-19
2.2%
Forecast Growth 19-24
Profit
Employment
12,871
Businesses
224

Industry Threats & Opportunities

  • Many pharmaceutical manufacturers will focus their product portfolio on developing biologic drugs
  • Many public and private payers have focused on bolstering generic drug usage to cut costs
  • Many provinces will move away from policies that benefit brand-name drug manufacturers
  • Industry Report - Industry Analysis Chapter

    The Brand-Name Pharmaceutical Manufacturing industry in Canada has benefited from increasing expenditure on prescription drugs and has been able to endure competition from generic drug sales. Patented drug sales as a share of total drug sales has remained stable during the period despite general declines in the prices for generic drug products. This trend has been driven by improving disposable income in Canada, in addition to innovative products that have attracted consumers toward brand-name pharmaceuticals. The per capita expenditure on patented drugs is expected to increase over the five years to 2019 and has primarily benefited from an increase in demand rather than prices. As ...purchase to read more.

    Additional Insights for the Brand-Name Pharmaceutical Manufacturing Industry

    IBISWorld identifies 250 Key Success Factors for a business.The most important for the Brand-Name Pharmaceutical Manufacturing Industry are

  • Establishment of brand names
  • Undertaking pharmaceutical and medicine R&D
  • Degree of globalization in the company
  • IBISWorld analysts also discuss how external factors such as Total health expenditure and Median age of population in the Brand-Name Pharmaceutical Manufacturing industry impact industry performance..

    shopping_cartPURCHASE OPTIONS

    What's in this report

    What is the Brand-Name Pharmaceutical Manufacturing Industry?

    This industry develops prescription and over-the-counter products used to treat illnesses in humans and animals. Brand-name drugs have patent protection. This industry does not include nutritional supplement or cosmetics manufacturers.

    Industry Products
  • Nervous system and cardiovascular drugs
  • Antineoplastic and immunomodulating agents
  • Alimentary tract and metabolism drugs
  • Respiratory system and sensory organ drugs
  • Antiinfectives and blood drugs
  • Musculoskeletal system drugs
  • Genitourinary and hormonal drugs
  • Industry Activities
  • Pharmaceutical research and development
  • Manufacturing active ingredients used in pharmaceuticals
  • Manufacturing chemical pharmaceutical preparations
  • Manufacturing biological pharmaceutical products
  • Table of Contents

    Industry Definition
    Main Activities
    Similar Industries
    Additional Resources
    Industry Statistics Snapshot
    Industry Structure
    Executive Summary
    Executive Summary
    Key External Drivers
  • Total health expenditure
  • Median age of population
  • R&D expenditures by pharmaceutical patentees
  • Canadian effective exchange rate index

  • Current Performance
  • Patent cliffs
  • Public and private payers
  • International trade and industry landscape
  • Chart: Revenue Growth

  • Industry Outlook
  • Changing products and markets
  • Industry structure
  • Table: Brand-Name Pharmaceutical Manufacturing Industry Revenue Outlook

  • Industry Life Cycle
  • Life cycle reasons
  • Chart: Benchmarking - Brand-Name Pharmaceutical Manufacturing Industry Lifecycle vs The Economy

  • Supply Chains
    Key Buying Industries
  • Supermarkets & Grocery Stores in Canada
  • Pharmacies & Drug Stores in Canada
  • Hospitals in Canada

  • Key Selling Industries
  • Biotechnology in Canada
  • Chemical Product Manufacturing in Canada
  • Medical Device Manufacturing in Canada
  • Medical Instrument & Supply Manufacturing in Canada
  • Navigational Instrument Manufacturing in Canada
  • Soap & Cleaning Compound Manufacturing in Canada

  • Products & Services
  • Antineoplastic and immunomodulating agents
  • Antiinfectives and blood drugs
  • Nervous system and cardiovascular drugs
  • Respiratory system and sensory organ drugs
  • Alimentary tract and metabolism drugs
  • Musculoskeletal system drugs
  • Genitourinary and hormonal drugs
  • Other
  • Chart: Brand-Name Pharmaceutical Manufacturing Industry Products and Services Segmentation

  • Demand Determinants
  • Public and private healthcare providers
  • Population demographics

  • Major Markets
  • Public sector
  • Canadian households
  • Private insurers
  • Chart: Major Market Segmentation for the Brand-Name Pharmaceutical Manufacturing Industry

  • International Trade
    Business Locations
    Chart: Business Locations by State
    Market Share Concentration
    Key Success Factors
    Cost Structure Benchmarks
    WagesPurchasesProfitDepreciationMarketingRentUtilitiesOther Costs
  • Chart: Cost Structure Benchmarking – Sector vs Brand-Name Pharmaceutical Manufacturing

  • Basis of Competition
    Internal competitionExternal competition
    Barriers to Entry
  • Table: Barrier to Entry Checklist for the Brand-Name Pharmaceutical Manufacturing Industry

  • Industry Globalization
    Pfizer Inc., Gilead Sciences Inc., Sanofi SA, Merck & Co. Inc.,
  • Table: Pfizer Inc. - financial performance
  • Table: Gilead Sciences Inc. - financial performance
  • Table: Sanofi SA - financial performance
  • Table: Merck & Co. Inc. - financial performance

  • Capital Intensity
  • Chart: Level of Capital Intensity for the Brand-Name Pharmaceutical Manufacturing Industry
  • Chart: Tools of the Trade: Growth Strategies for Success

  • Technology & Systems
    Revenue Volatility
  • Chart: Volatility vs Industry Growth

  • Regulation & Policy
    Industry Assistance
    Table: Industry Data for the Brand-Name Pharmaceutical Manufacturing Industry
    Includes:
  • Industry Revenue (2010-2024)
  • Industry Gross Product (2010-2024)
  • Establishments (2010-2024)
  • Businesses (2010-2024)
  • Employment (2010-2024)
  • Exports (2010-2024)
  • Imports (2010-2024)
  • Wages (2010-2024)
  • Wages (2010-2024)
  • Purchases (2010-2024)
  • Profit (2010-2024)
  • Depreciation (2010-2024)
  • Marketing (2010-2024)
  • Rent (2010-2024)
  • Utilities (2010-2024)
  • Other (2010-2024)
  • Total healthcare expenditure (2010-2024)

  • Table: Annual Percentage Change for Key Industry Data
    Table: Key Ratios for Industry Key Data
    Biologic
  • A drug made from large-molecule living matter, as opposed to small-molecule chemicals.
  • Biosimilar
  • A drug derived from living organisms and marketed after the patent expiration of similar therapies. Also known as flow-on biologics or biogenerics.
  • Blockbuster Drug
  • A drug that generates annual sales of more than $1.0 billion.
  • Patent Cliff
  • The period when numerous patents on blockbuster drugs are set to expire.
  • What Our Customers Say

    Why buy this report?

    IBISWorld’s Brand-Name Pharmaceutical Manufacturing market research report is a comprehensive guide to market size and growth prospects. Our industry reports offer strategic industry analysis of the factors influencing companies, including new product developments, economic, lifestyle and demographic influences, distribution and supply chain factors and pricing issues. Full analysis accompanies our data forecasts to illustrate how the market responds to emerging industry trends.

    IBISWorld industry market research reports enable you to:
    • Find out about key industry trends
    • Identify threats and opportunities
    • Inform your decisions for marketing, strategy and planning
    • Quickly build competitive intelligence
    This report on Brand-Name Pharmaceutical Manufacturing:
    • Provides Market Size information to assist with planning and strategic decisions.
    • Includes the necessary information to perform SWOT, PEST and STEER analysis.
    • Helps you understand market dynamics to give you a deeper understanding of industry competition and the supply chain.
    • Analyses key performance and operational metrics so that you can benchmark against your own business, that of your customers’ businesses, or your competitors’ businesses.
    The Brand-Name Pharmaceutical Manufacturing market research report includes:
    • Historical data and analysis for the key drivers of this industry
    • A five-year forecast of the market and noted trends
    • Detailed research and segmentation for the main products and markets
    • An assessment of the competitive landscape and market shares for major companies
    • And of course, much more

    IBISWorld reports on thousands of industries around the world. Our clients rely on our information and data to stay up-to-date on industry trends across all industries. With this IBISWorld Industry Research Report on Brand-Name Pharmaceutical Manufacturing, you can expect thoroughly researched, reliable and current information that will help you to make faster, better business decisions.

    Contact Us

    Want to speak to a representative? Call us.

    clear